ADAR1 Capital Management reports acquisition of $12,718.7996 in InMed Pharmaceuticals common shares
ADAR1 Capital Management reported purchases of 9,569 InMed Pharmaceuticals common shares, increasing indirect beneficial ownership to 955,493 shares. Purchases comprised 8,585 shares at $1.33 each and 984 shares at $1.3219 each. Daniel Schneeberger, manager of ADAR1 Capital Management, was also listed as a reporting ow